232 related articles for article (PubMed ID: 25055363)
1. The quest for a better understanding of chronic kidney disease complications: an update on uremic toxins.
Barreto FC; Stinghen AE; de Oliveira RB; Franco AT; Moreno AN; Barreto DV; Pecoits-Filho R; Drüeke TB; Massy ZA
J Bras Nefrol; 2014; 36(2):221-35. PubMed ID: 25055363
[TBL] [Abstract][Full Text] [Related]
2. Cerebro-renal interactions: impact of uremic toxins on cognitive function.
Watanabe K; Watanabe T; Nakayama M
Neurotoxicology; 2014 Sep; 44():184-93. PubMed ID: 25003961
[TBL] [Abstract][Full Text] [Related]
3. The specific impact of uremic toxins upon cognitive domains: a review.
Franco ÁO; Starosta RT; Roriz-Cruz M
J Bras Nefrol; 2019; 41(1):103-111. PubMed ID: 30095142
[TBL] [Abstract][Full Text] [Related]
4. Uremic Toxins and Vascular Dysfunction.
Six I; Flissi N; Lenglet G; Louvet L; Kamel S; Gallet M; Massy ZA; Liabeuf S
Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32570781
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β
Yamamoto S
Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease.
Claro LM; Moreno-Amaral AN; Gadotti AC; Dolenga CJ; Nakao LS; Azevedo MLV; de Noronha L; Olandoski M; de Moraes TP; Stinghen AEM; Pécoits-Filho R
Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30249039
[TBL] [Abstract][Full Text] [Related]
7. Uremic Toxins and Frailty in Patients with Chronic Kidney Disease: A Molecular Insight.
Chao CT; Lin SH
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200937
[TBL] [Abstract][Full Text] [Related]
8. [Fragility Fractures in Hemodialysis Patients. Uremic toxins-related abnormal bone metabolism.].
Yamamoto S
Clin Calcium; 2018; 28(8):1093-1100. PubMed ID: 30049919
[TBL] [Abstract][Full Text] [Related]
9. Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome.
Lekawanvijit S
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30200452
[TBL] [Abstract][Full Text] [Related]
10. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
Liu WC; Tomino Y; Lu KC
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
[TBL] [Abstract][Full Text] [Related]
11. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets.
Lim YJ; Sidor NA; Tonial NC; Che A; Urquhart BL
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33668632
[TBL] [Abstract][Full Text] [Related]
12. Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease.
El Chamieh C; Larabi IA; Laville SM; Jacquelinet C; Combe C; Fouque D; Laville M; Frimat L; Pecoits-Filho R; Lange C; Stengel B; Alencar De Pinho N; Alvarez JC; Massy ZA; Liabeuf S;
Toxins (Basel); 2023 Apr; 15(4):. PubMed ID: 37104214
[TBL] [Abstract][Full Text] [Related]
13. Uremic Toxicity and Bone in CKD.
Yamamoto S; Fukagawa M
J Nephrol; 2017 Oct; 30(5):623-627. PubMed ID: 28573386
[TBL] [Abstract][Full Text] [Related]
14. Understanding and Therapeutic Strategies of Chinese Medicine on Gut-Derived Uremic Toxins in Chronic Kidney Disease.
Guo C; Rao XR
Chin J Integr Med; 2018 Jun; 24(6):403-405. PubMed ID: 29752692
[TBL] [Abstract][Full Text] [Related]
15. Adynamic bone disease is a predominant bone pattern in early stages of chronic kidney disease.
Massy Z; Drueke T
J Nephrol; 2017 Oct; 30(5):629-634. PubMed ID: 28405928
[TBL] [Abstract][Full Text] [Related]
16. Effect of uremic toxin-indoxyl sulfate on the skeletal system.
Liu WC; Wu CC; Lim PS; Chien SW; Hou YC; Zheng CM; Shyu JF; Lin YF; Lu KC
Clin Chim Acta; 2018 Sep; 484():197-206. PubMed ID: 29864403
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.
Vanholder R; Pletinck A; Schepers E; Glorieux G
Toxins (Basel); 2018 Jan; 10(1):. PubMed ID: 29316724
[TBL] [Abstract][Full Text] [Related]
18. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease.
Wu CL; Tarng DC
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419312
[TBL] [Abstract][Full Text] [Related]
19. Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?
Evenepoel P; Rodriguez M; Ketteler M
Semin Nephrol; 2014 Mar; 34(2):151-63. PubMed ID: 24780470
[TBL] [Abstract][Full Text] [Related]
20. Review of the efficacy of AST-120 (KREMEZIN
Asai M; Kumakura S; Kikuchi M
Ren Fail; 2019 Nov; 41(1):47-56. PubMed ID: 30732506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
